KUBANDA CRYOTHERAPY, INC.

BALTIMORE, MD · Founded 2018 · Medtech · Private

Low-cost cryotherapy device using carbon dioxide for minimally-invasive breast cancer treatment in resource-limited settings

Claim this profile

Follows are private to you and power your alerts

Updated · kubandacryotherapy.com

Sector
Medtech
Headquarters
BALTIMORE, MD
Founded
2018
Latest Form D
$200K, Apr 2024
Total capital
$2.8M
Federal grants
$1.8M
2 awards · 2021–2025
Rank in peer group#452 of 538
Private capital raised
$1M
3 Form D · last Apr 2024
30 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20212022202320242025FEDERAL ↑EQUITY ↓Cumulative $2.8M$400K$1.4M1st Form D$100K2nd Form D$725K
20212022202320242025FEDERAL ↑EQUITY ↓Cumulative $2.8M$400K$1.4M1st Form D$100K2nd Form D$725K

Latest events

  • Federal grantHealth and Human S · Phase II · Low Cost Carbon Dioxide-Based Cryoablation for Breast Cancer Treatment in Low Resource Settings$1.4M
  • Private capital raisedForm D · SEC · 3rd filing$200K
  • Private capital raisedForm D · SEC · 2nd filing$725K
  • Federal grantHealth and Human S · Phase I · Low Cost Carbon Dioxide-Based Cryoablation for Breast Cancer Treatment in Low Resource Settings$400K
  • Private capital raisedForm D · SEC · 1st filing$100K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Bailey SurteesResearcherExecutive Officer, Director, PromoterLinked by $1.8M in grants as PI
  • Yixin HuExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .